Controversies in the management of germ cell tumours of the ovary
- 1 September 2006
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Oncology
- Vol. 18 (5), 500-506
- https://doi.org/10.1097/01.cco.0000239891.44031.38
Abstract
Ovarian germ cell tumours are rare, but curable at all stages of disease. This review gives an outline of the main controversies regarding the management of this disease. Pelvic malignancies are very rare during pregnancy, which should avoid the need for radical surgery or termination in these patients. Also during pregnancy, AFP-L2 looks to be a promising tumour marker in detecting relapse. Malignant transformation of mature teratomas may be predicted by preoperative squamous cell antigen and tumour size. OCT4 immunohistochemistry has been shown to be a very useful adjunct in the diagnosis of dysgerminomas. The traditional method for grading immature teratomas is challenged by a new classification. Patients receiving cisplatin-based chemotherapy are at a higher risk of developing cardiovascular risk factors. There is a hint that high-dose chemotherapy may play a role in relapsed patients. Rarity of the disease means many controversies are difficult to resolve, with much reliance on using data from testicular cancer studies. Many clinicians still advocate adjuvant chemotherapy for stage I nondysgerminomatous tumours of grade 2 and above despite good evidence that surveillance is a safe option, and increasing concerns about life-threatening long-term effects of treatment.Keywords
This publication has 47 references indexed in Scilit:
- Coexistence of Graves’ disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levelsJournal of Endocrinological Investigation, 2005
- Ovarian germ cell tumors in children: A clinical study of 66 patientsPediatric Blood & Cancer, 2005
- Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratomaAnnals of Neurology, 2005
- Meigs syndrome and gliomatosis peritonei: A case report and review of literatureGynecologic Oncology, 2005
- Gynecologic Malignancies in Women Aged Less Than 25 YearsObstetrics & Gynecology, 2005
- Ovarian cancer incidence in the United States, 1992–1999Gynecologic Oncology, 2005
- Ovarian dysgerminoma associated with Pseudo-Meigs' syndrome and functioning ovarian stroma: a case reportGynecologic Oncology, 2005
- Pseudo-Meigs syndrome and elevated CA125 associated with struma ovariiGynecologic Oncology, 2005
- Ovarian masses during adolescence: clinical, ultrasonographic and pathologic findings, serum tumor markers and endocrinological profileGynecological Endocrinology, 2004
- Management of Non-Epithelial Ovarian TumoursOncology, 1999